CN102300583A - Goodpasture抗原结合蛋白及其检测 - Google Patents

Goodpasture抗原结合蛋白及其检测 Download PDF

Info

Publication number
CN102300583A
CN102300583A CN2009801322315A CN200980132231A CN102300583A CN 102300583 A CN102300583 A CN 102300583A CN 2009801322315 A CN2009801322315 A CN 2009801322315A CN 200980132231 A CN200980132231 A CN 200980132231A CN 102300583 A CN102300583 A CN 102300583A
Authority
CN
China
Prior art keywords
gpbp
polypeptide
seq
kda
antibody
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2009801322315A
Other languages
English (en)
Chinese (zh)
Inventor
J·索斯
F·瑞维尔特
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
FibroStatin SL
Original Assignee
FibroStatin SL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by FibroStatin SL filed Critical FibroStatin SL
Publication of CN102300583A publication Critical patent/CN102300583A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G16H10/60—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/23—Immunoglobulins specific features characterized by taxonomic origin from birds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/54—F(ab')2
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y207/00—Transferases transferring phosphorus-containing groups (2.7)
    • C12Y207/11—Protein-serine/threonine kinases (2.7.11)
    • C12Y207/11009—Goodpasture-antigen-binding protein kinase (2.7.11.9)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/91—Transferases (2.)
    • G01N2333/912—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
    • Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Primary Health Care (AREA)
  • Public Health (AREA)
  • Medical Informatics (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
CN2009801322315A 2008-07-22 2009-07-20 Goodpasture抗原结合蛋白及其检测 Pending CN102300583A (zh)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US8274108P 2008-07-22 2008-07-22
US61/082,741 2008-07-22
US8521108P 2008-07-31 2008-07-31
US61/085,211 2008-07-31
PCT/EP2009/005258 WO2010009856A2 (en) 2008-07-22 2009-07-20 Goodpasture antigen binding protein and its detection

Publications (1)

Publication Number Publication Date
CN102300583A true CN102300583A (zh) 2011-12-28

Family

ID=41202276

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2009801322315A Pending CN102300583A (zh) 2008-07-22 2009-07-20 Goodpasture抗原结合蛋白及其检测

Country Status (6)

Country Link
US (3) US7935492B2 (enExample)
EP (1) EP2318039B1 (enExample)
JP (1) JP5654989B2 (enExample)
CN (1) CN102300583A (enExample)
ES (1) ES2535258T3 (enExample)
WO (1) WO2010009856A2 (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107966569A (zh) * 2017-12-27 2018-04-27 湖北普罗金科技有限公司 一种具有冷却通风功能的蛋白质鉴定工作台
CN119322175A (zh) * 2024-10-18 2025-01-17 武汉塞力斯生物技术有限公司 一种血管炎抗体联检试剂盒

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010009856A2 (en) * 2008-07-22 2010-01-28 Juan Saus Goodpasture antigen binding protein and its detection
AU2012219582A1 (en) 2011-02-21 2013-08-22 Fibrostatin S.L. Methods for treating and diagnosing disease
US9066938B2 (en) 2012-07-02 2015-06-30 Fibrostein, S.L. GPBP-1 inhibition and its therapeutic use
JP2016534981A (ja) * 2013-09-27 2016-11-10 フィブロスタティン，エス．エル． 糖尿病におけるグッドパスチャー抗原結合タンパク質の検出および阻害ならびにその使用
US20160184274A1 (en) 2014-12-31 2016-06-30 Fibrostatin, S.L. Methods for inhibiting mesenchymal phenotype after epithelial-to-mesenchymal transition
WO2025032091A1 (en) * 2023-08-08 2025-02-13 F. Hoffmann-La Roche Ag Peptide biomarker for neurological disease, in particular motor neuron disease

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000050607A2 (en) * 1999-02-24 2000-08-31 Juan Saus Goodpasture antigen binding protein
WO2004070025A2 (en) * 2003-02-05 2004-08-19 Juan Saus Novel goodpasture antigen-binding protein isoforms and protein misfolded-mediated disorders

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5776427A (en) 1992-03-05 1998-07-07 Board Of Regents, The University Of Texas System Methods for targeting the vasculature of solid tumors
US5625048A (en) 1994-11-10 1997-04-29 The Regents Of The University Of California Modified green fluorescent proteins
US6124128A (en) 1996-08-16 2000-09-26 The Regents Of The University Of California Long wavelength engineered fluorescent proteins
US6881547B1 (en) 2001-01-31 2005-04-19 Juan Saus Methods and reagents for treating autoimmune disorders
US7147855B2 (en) 2001-12-07 2006-12-12 Juan Saus GIPs, a family of polypeptides with transcription factor activity that interact with goodpasture antigen binding protein
WO2010009856A2 (en) * 2008-07-22 2010-01-28 Juan Saus Goodpasture antigen binding protein and its detection

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000050607A2 (en) * 1999-02-24 2000-08-31 Juan Saus Goodpasture antigen binding protein
WO2004070025A2 (en) * 2003-02-05 2004-08-19 Juan Saus Novel goodpasture antigen-binding protein isoforms and protein misfolded-mediated disorders

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
REVERT FERNANDO ET AL: "Increased goodpasture antigen-binding protein expression induces type IV collagen disorganization and deposit of immunoglobulin A in glomerular basement membrane", 《THE AMERICAN JOURNAL OF PATBOLOGY》 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107966569A (zh) * 2017-12-27 2018-04-27 湖北普罗金科技有限公司 一种具有冷却通风功能的蛋白质鉴定工作台
CN119322175A (zh) * 2024-10-18 2025-01-17 武汉塞力斯生物技术有限公司 一种血管炎抗体联检试剂盒

Also Published As

Publication number Publication date
US20100021935A1 (en) 2010-01-28
JP2011528559A (ja) 2011-11-24
ES2535258T3 (es) 2015-05-07
WO2010009856A2 (en) 2010-01-28
US20110189707A1 (en) 2011-08-04
EP2318039B1 (en) 2015-04-08
JP5654989B2 (ja) 2015-01-14
US7935492B2 (en) 2011-05-03
WO2010009856A3 (en) 2010-05-20
US20150064716A1 (en) 2015-03-05
EP2318039A2 (en) 2011-05-11

Similar Documents

Publication Publication Date Title
US20150064716A1 (en) Goodpasture Antigen Binding Protein and Its Detection
US20220056118A1 (en) Antibodies to misfolded tdp-43 and methods of use
CN113508300A (zh) 用于人类阿尔茨海默病的新型生物标记物
JPWO2008013257A1 (ja) 可溶型ｌｏｘ−１に対するモノクローナル抗体
WO2003093474A1 (en) Psp94 binding protein and psp94 diagnostic assays
US7932043B2 (en) Use of monoclonal antibodies to distinguish protein conformational isoforms
GB2585252A (en) Tau epitope and binding molecules
US20220218805A1 (en) Conformation-specific epitopes in tau, antibodies thereto and methods related thereof
EP1725870A1 (en) Anti-lipid rafts antibodies
WO2024101357A1 (ja) コートマータンパク質複合体サブユニットベータ２に対する抗体
JP2024509683A (ja) 抗ｐｔ２１７ ｔａｕ抗体
US20180086844A1 (en) Antibodies against mammal secreted klotho protein
KR102886496B1 (ko) Mlc1 단백질에 특이적으로 결합하는 단일클론항체 및 이의 용도
WO2020100779A1 (ja) ｐＳｅｒ４６－ＭＡＲＣＫＳに特異的に結合するモノクローナル抗体
CA3192058A1 (en) Anti-ceruloplasmin antibodies and uses thereof
HK40085952A (en) Apolipoprotein l1-specific antibodies and methods of use
EA045911B1 (ru) АНТИТЕЛА К ПИРОГЛУТАМАТ-β-АМИЛОИДУ И ИХ ПРИМЕНЕНИЕ
JP2018080131A (ja) Ｄｒｄ１由来のタグペプチド及びｄｒｄ１を認識する抗体
Oboznaya et al. Production of monoclonal antibodies to the prion protein and their characterization
JP2011251969A (ja) 抗ヒト肝性トリグリセリドリパーゼ抗体
KR20120032320A (ko) 인간 ｐｉｎｋ1 단백질의 아미노 말단이 절단된 단백질을 인지하는 단클론 항체 및 이의 용도
JP2009173612A (ja) モノクローナル抗ヒトホモシステイン誘導小胞体（ＥＲ）蛋白Ｈｅｒｐ抗体

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20111228